By Matthew Brady 
A first-of-its-kind Declaration on Longevity and Precision Medicine has been unveiled at Abu Dhabi Global Health Week, setting out key principles to accelerate progress in precision medicine and longevity science.
Developed in collaboration with global experts, the declaration seeks to drive the adoption of personalised care and advance research aimed at extending healthy lifespans. It also highlights the urgent need to address the growing gap between healthspan and lifespan, which now approaches a decade worldwide.
The declaration, led by Department of Health – Abu Dhabi (DoH), makes bold commitments to propel longevity science, AI-driven diagnostics, and personalised therapeutics.
It is structured around six core pillars: advancing research and innovation; fostering collaboration and knowledge-sharing; investing in education and workforce development; advocating for supportive policy and regulation; upholding ethical and responsible practices; and engaging the public on the promise and implications of longevity research.
Signatories to the declaration included M42, Masdar City, PureHealth, Illumina, NYU Abu Dhabi, the University of Pennsylvania, Aldar, Children’s National Hospital, Burjeel, the Children’s Hospital of Philadelphia, and the Institute for Healthier Living Abu Dhabi (IHLAD).
